RANZCR,in partnership with Eligard (Mundipharma), will run a monthly FROGG GU, virtual webinarprogram facilitated by both national and international speakers for Radiation Oncology Trainees.
Three education sessions will run in September/ October/ November with more planned for 2021.
Registration is free for RANZCR Trainees.
The first session will be with Dr Anthony D'Amico.Chief of Genitourinary Radiation Oncology at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Chair of the residency executive committee in the Harvard Radiation Oncology Program, and Advisory Dean and Chair of career advising and mentorship at Harvard medical School.
Click here to read Dr D'Amico's full Bio
Date and Time: Monday September 28th, 7:30 am. Topic: Risk Based Management of Prostate Cancer
Will review the level 1 evidence that supports treatment paradigms in the management of prostate cancer stratified by risk group. The evidence supporting the evolving paradigm of treatment for men with oligo metastatic disease will also be presented.